Organogenesis Holdings Reports Strong Q4 2024 Results
PremiumCompany AnnouncementsOrganogenesis Holdings Reports Strong Q4 2024 Results
1M ago
Organogenesis sees FY25 revenue $480M-$535M, consensus $472.94M
Premium
The Fly
Organogenesis sees FY25 revenue $480M-$535M, consensus $472.94M
1M ago
Organogenesis reports Q4 EPS 4c, consensus 2c
Premium
The Fly
Organogenesis reports Q4 EPS 4c, consensus 2c
1M ago
Organogenesis Holdings Secures $130M Investment for Growth
PremiumCompany AnnouncementsOrganogenesis Holdings Secures $130M Investment for Growth
5M ago
Organogenesis Reports Robust Third Quarter Growth
Premium
Company Announcements
Organogenesis Reports Robust Third Quarter Growth
5M ago
Organogenesis reports Q3 EPS 9c, consensus (1c)
Premium
The Fly
Organogenesis reports Q3 EPS 9c, consensus (1c)
5M ago
Is ORGO a Buy, Before Earnings?
PremiumPre-EarningsIs ORGO a Buy, Before Earnings?
5M ago
Organogenesis trial results show safety, efficacy of NuShield for  DFUs
Premium
The Fly
Organogenesis trial results show safety, efficacy of NuShield for DFUs
6M ago
Organogenesis announces development program update for ReNu
Premium
The Fly
Organogenesis announces development program update for ReNu
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100